Abingworth LLP 13D and 13G filings for eFFECTOR Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-03 4:00 pm Purchase | 2021-08-25 | 13D | eFFECTOR Therapeutics, Inc. EFTR | Abingworth LLP | 192,885 11.900% | 192,885 (New Position) | Filing |